Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-14

FDA Approved: PIRFENIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for pirfenidone filed by ANI Pharmaceuticals, Inc., updating the drug's approval status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PIRFENIDONE (pirfenidone)

Snippet

SUPPL AP for PIRFENIDONE (PIRFENIDONE)